The variant fetal hemoglobin F Texas I is abnormally acetylated

A S Keitt1, R T Jones

  • 1Department of Pathology, University of Florida College of Medicine, Gainesville 32610.

Insights

This study identifies a novel fetal hemoglobin variant, Hb F Texas I, in infants. This variant exhibits increased N-alpha-acetylation, a previously undocumented phenomenon in abnormal fetal hemoglobins.

Area of Science:

  • Hematology
  • Biochemistry
  • Genetics

Background:

  • Fetal hemoglobin (HbF) plays a crucial role in oxygen transport during gestation.
  • Hemoglobin variants can arise from genetic mutations, potentially affecting oxygen-carrying capacity and stability.
  • Electrophoretic screening of cord blood is a standard method for detecting hemoglobinopathies.

Purpose of the Study:

  • To characterize a novel hemoglobin variant detected in infants.
  • To elucidate the molecular basis and post-translational modifications of this variant.
  • To investigate the acetylation status of the identified abnormal fetal hemoglobin.

Main Methods:

  • Electrophoretic cord blood screening
  • Isoelectric focusing (IEF)
  • Anion exchange chromatography (AEC)
  • High-performance liquid chromatography (HPLC)
  • Tryptic hydrolysis and peptide analysis
  • Edman degradation
  • Fast atom bombardment mass spectrometry (FABMS)

Main Results:

  • A novel fetal hemoglobin variant, Hb F Texas I, was identified in two related infants.
  • Structural analysis revealed a glu----lys substitution at position 5 in the A gamma T-1 peptide.
  • A minor fraction of Hb F Texas I chains showed resistance to Edman degradation, indicating acetylation.
  • FABMS confirmed N-alpha-acetylation of the variant, with acetylation levels nearly three times higher than normal HbF.
  • This increased acetylation was stable over a year in the proband.

Conclusions:

  • Hb F Texas I is a novel variant of fetal hemoglobin characterized by a specific amino acid substitution.
  • This variant exhibits significantly increased N-alpha-acetylation, a novel finding for abnormal fetal hemoglobins.
  • The increased acetylation may represent a compensatory mechanism or a unique characteristic of this hemoglobinopathy.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Transfer RNA Synthesis02:36

Transfer RNA Synthesis

One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...